In a crucial legal development, TorHoerman Law secured a $495 million verdict against Abbott Laboratories Inc. on July 26. The case centered around Robynn Davis, an infant who deteriorated after being given Similac formula in the neonatal intensive care unit in 2021, according to her mother’s attorney, Jake Plattenberger. As Plattenberger details, jurors were moved by evidence showing that Robynn was medically stable and progressing well until she received Abbott’s product. More information on this case can be found here.